The FDA’s database shows that the Lactulose product (brand name Lactulose) is an oral and rectal solution marketed under product number 001. It contains the active ingredient Lactulose at a strength of 10 g/15 mL and is not a reference drug.
According to the FDA entry, the marketing status of this product is listed as discontinued. The application is identified by NDA017906 and the sponsor is Solvay.
Regulatorische Updates28. Sept. 2026•1 Min. Lesezeit
FDA Discontinues Lactulose Oral/Rectal Solution (NDA017906)
The FDA has listed the Lactulose oral and rectal solution (product #001) as discontinued under NDA017906, sponsored by Solvay.
Zusammengestellt vom PharmaCountry-Team · Quelle: FDA.gov
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen